Published in
Esmo Open, Esmo Open, 5(7), p. 100574, 2022
DOI: 10.1016/j.esmoop.2022.100574
Links
Tools
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern
Journal article published in 2022 by
A. Lasagna 
,
F. Bergami,
D. Lilleri,
E. Percivalle,
M. Quaccini,
F. Serra,
G. Comolli,
A. Sarasini,
J. C. Sammartino,
A. Ferrari,
F. Arena,
S. Secondino,
D. Cicognini,
R. Schiavo,
G. Lo Cascio
and other authors.
,
F. Bergami,
D. Lilleri,
E. Percivalle,
M. Quaccini,
F. Serra,
G. Comolli,
A. Sarasini,
J. C. Sammartino,
A. Ferrari,
F. Arena,
S. Secondino,
D. Cicognini,
R. Schiavo,
G. Lo Cascio
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 